Ingredion (INGR) Financials

Ingredion logo
$92.96 -1.18 (-1.25%)
Closing price 03:59 PM Eastern
Extended Trading
$92.22 -0.74 (-0.79%)
As of 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Ingredion

Annual Income Statements for Ingredion

This table shows Ingredion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
402 485 519 443 413 348 117 492 643 647 729
Consolidated Net Income / (Loss)
412 496 532 454 424 354 125 502 651 654 736
Net Income / (Loss) Continuing Operations
412 496 532 454 424 354 125 502 651 654 736
Total Pre-Tax Income
599 742 769 621 582 506 248 668 839 931 974
Total Operating Income
660 806 836 703 664 582 310 762 957 883 1,016
Total Gross Profit
1,242 1,401 1,472 1,368 1,312 1,272 1,331 1,494 1,749 1,791 1,828
Total Revenue
5,621 5,704 6,244 6,289 6,209 5,987 6,894 7,946 8,160 7,430 7,219
Operating Revenue
5,621 5,704 6,244 6,289 6,209 5,987 6,894 7,946 8,160 7,430 7,219
Total Cost of Revenue
4,379 4,303 4,772 4,921 4,897 4,715 5,563 6,452 6,411 5,639 5,391
Operating Cost of Revenue
4,379 4,303 4,772 4,921 4,897 4,715 5,563 6,452 6,411 5,639 5,391
Total Operating Expenses
582 595 636 665 648 690 1,021 732 792 908 812
Selling, General & Admin Expense
- - 616 611 610 628 668 715 789 782 815
Other Operating Expenses / (Income)
-1.00 -4.00 -18 -10 -19 -31 -34 13 -8.00 -1.00 -24
Restructuring Charge
583 599 38 64 57 93 387 4.00 11 127 21
Total Other Income / (Expense), net
-61 -64 -67 -82 -82 -76 -62 -94 -118 48 -42
Interest Expense
61 66 73 86 81 81 74 99 114 39 37
Other Income / (Expense), net
- 2.00 6.00 4.00 -1.00 5.00 12 5.00 -4.00 87 -5.00
Income Tax Expense
187 246 237 167 158 152 123 166 188 277 238
Net Income / (Loss) Attributable to Noncontrolling Interest
10 11 13 11 11 6.00 8.00 10 8.00 7.00 7.00
Basic Earnings per Share
$5.62 $6.70 $7.21 $6.25 $6.17 $5.18 $1.74 $7.43 $9.74 $9.88 $11.36
Weighted Average Basic Shares Outstanding
71.60M 72.30M 72M 70.90M 66.90M 67.20M 67.10M 66.20M 66M 65.50M 64.20M
Diluted Earnings per Share
$5.51 $6.55 $7.06 $6.17 $6.13 $5.15 $1.73 $7.34 $9.60 $9.71 $11.18
Weighted Average Diluted Shares Outstanding
73M 74.10M 73.50M 71.80M 67.40M 67.60M 67.80M 67M 67M 66.60M 65.20M
Weighted Average Basic & Diluted Shares Outstanding
71.50M 72.40M 72M 70.90M 66.88M 67.11M 66.71M 65.95M 65.56M 64.19M 62.95M
Cash Dividends to Common per Share
- $1.90 $2.20 $2.45 $2.51 $2.54 $2.58 $2.72 $2.98 $3.16 $3.24

Quarterly Income Statements for Ingredion

This table shows Ingredion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
216 148 188 95 197 196 171 165 142 114 142
Consolidated Net Income / (Loss)
218 150 189 97 199 198 172 167 144 116 142
Net Income / (Loss) Continuing Operations
218 150 189 97 199 198 172 167 144 116 142
Total Pre-Tax Income
276 230 273 152 267 259 241 207 194 175 194
Total Operating Income
213 240 268 162 276 271 249 220 203 188 201
Total Gross Profit
417 446 479 449 466 477 455 430 401 426 399
Total Revenue
1,882 1,878 1,870 1,800 1,813 1,833 1,816 1,757 1,792 1,850 1,792
Operating Revenue
1,882 1,878 1,870 1,800 1,813 1,833 1,816 1,757 1,792 1,850 1,792
Total Cost of Revenue
1,465 1,432 1,391 1,351 1,347 1,356 1,361 1,327 1,391 1,424 1,393
Operating Cost of Revenue
1,465 1,432 1,391 1,351 1,347 1,356 1,361 1,327 1,391 1,424 1,393
Total Operating Expenses
204 206 211 287 190 206 206 210 198 238 198
Selling, General & Admin Expense
189 191 198 204 193 208 203 211 200 207 215
Other Operating Expenses / (Income)
12 -8.00 1.00 -6.00 -10 -5.00 0.00 -9.00 -13 -14 -3.00
Restructuring Charge
3.00 23 12 89 7.00 3.00 3.00 8.00 11 45 -14
Total Other Income / (Expense), net
63 -10 5.00 -10 -9.00 -12 -8.00 -13 -9.00 -13 -7.00
Interest Expense
19 10 1.00 9.00 9.00 12 7.00 9.00 9.00 55 5.00
Other Income / (Expense), net
82 0.00 6.00 -1.00 - 0.00 -1.00 -4.00 - 42 -2.00
Income Tax Expense
58 80 84 55 68 61 69 40 50 59 52
Net Income / (Loss) Attributable to Noncontrolling Interest
2.00 2.00 1.00 2.00 2.00 2.00 1.00 2.00 2.00 2.00 0.00
Basic Earnings per Share
$3.29 $2.25 $2.88 $1.46 $3.05 $3.04 $2.66 $2.61 $2.25 $1.80 $2.25
Weighted Average Basic Shares Outstanding
65.70M 65.70M 65.30M 65.50M 64.50M 64.50M 64.30M 64.20M 63.20M 63.30M 63.10M
Diluted Earnings per Share
$3.23 $2.22 $2.83 $1.43 $3.00 $2.99 $2.61 $2.58 $2.22 $1.78 $2.23
Weighted Average Diluted Shares Outstanding
66.80M 66.80M 66.50M 66.60M 65.60M 65.60M 65.40M 65.20M 64M 63.90M 63.70M
Weighted Average Basic & Diluted Shares Outstanding
65.65M 65.06M 65.16M 64.19M 64.31M 64.18M 63.53M 62.95M 63.06M 63.06M 62.29M

Annual Cash Flow Statements for Ingredion

This table details how cash moves in and out of Ingredion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-146 82 83 -247 -63 401 -337 -92 165 596 33
Net Cash From Operating Activities
686 771 769 703 680 829 392 152 1,057 1,436 944
Net Cash From Continuing Operating Activities
686 771 769 703 680 829 392 152 1,057 1,436 944
Net Income / (Loss) Continuing Operations
412 496 532 454 424 354 125 502 651 654 736
Consolidated Net Income / (Loss)
412 496 532 454 424 354 125 502 651 654 736
Depreciation Expense
194 196 209 247 220 213 220 215 219 214 222
Non-Cash Adjustments To Reconcile Net Income
106 101 105 96 90 159 403 112 131 113 120
Changes in Operating Assets and Liabilities, net
-26 -22 -77 -94 -54 103 -356 -677 56 455 -134
Net Cash From Investing Activities
-649 -689 -326 -361 -374 -571 -335 -320 -329 -47 -444
Net Cash From Continuing Investing Activities
-649 -689 -326 -361 -374 -571 -335 -320 -329 -47 -444
Purchase of Property, Plant & Equipment
-280 -284 -314 -350 -328 -340 -300 -300 -314 -295 -433
Purchase of Investments
- -2.00 -3.00 -15 - - - - -9.00 -4.00 -20
Divestitures
- - - - - - - 0.00 0.00 255 12
Other Investing Activities, net
- - - 2.00 -6.00 -2.00 -13 2.00 -6.00 -3.00 -3.00
Net Cash From Financing Activities
-116 0.00 -375 -589 -364 143 -373 103 -569 -765 -491
Net Cash From Continuing Financing Activities
-116 0.00 -375 -589 -364 143 -373 103 -569 -765 -491
Repayment of Debt
-1,366 - -1,240 -738 -1,465 -1,233 -1,440 -532 -1,012 -1,118 -449
Repurchase of Common Equity
-41 -8.00 -123 -657 66 0.00 -68 -158 -103 -256 -224
Payment of Dividends
-126 141 -165 -182 -174 -178 -184 -181 -194 -210 -211
Issuance of Debt
1,388 1,880 1,144 987 1,209 1,550 1,300 965 720 773 405
Other Financing Activities, net
8.00 - - - - - - - 20 46 -12
Effect of Exchange Rate Changes
-67 - - - - 0.00 -21 -27 6.00 -28 24

Quarterly Cash Flow Statements for Ingredion

This table details how cash moves in and out of Ingredion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
37 67 372 120 -160 24 54 115 -116 34 41
Net Cash From Operating Activities
209 312 479 436 77 185 277 405 33 90 266
Net Cash From Continuing Operating Activities
209 312 479 436 77 185 277 405 33 90 266
Net Income / (Loss) Continuing Operations
218 150 189 97 199 198 172 167 144 116 142
Consolidated Net Income / (Loss)
218 150 189 97 199 198 172 167 144 116 142
Depreciation Expense
53 54 53 54 55 53 57 57 55 55 55
Non-Cash Adjustments To Reconcile Net Income
-36 37 6.00 106 37 23 24 36 29 52 10
Changes in Operating Assets and Liabilities, net
-26 71 231 179 -214 -89 24 145 -195 -133 59
Net Cash From Investing Activities
181 -56 -46 -126 -78 -125 -87 -142 -100 -2.00 -67
Net Cash From Continuing Investing Activities
181 -56 -46 -126 -78 -125 -87 -142 -100 -2.00 -67
Purchase of Property, Plant & Equipment
-65 -55 -50 -131 -92 -101 -105 -135 -110 -100 -103
Net Cash From Financing Activities
-347 -179 -75 -164 -166 -50 -136 -151 -48 -53 -157
Net Cash From Continuing Financing Activities
-347 -179 -75 -164 -166 -50 -136 -151 -48 -53 -157
Repayment of Debt
-446 143 -563 -252 -154 -111 -96 -88 -123 -108 -100
Repurchase of Common Equity
-1.00 -105 -21 -129 -55 - -79 -90 -21 - -98
Payment of Dividends
-51 -53 -52 -54 -52 -54 -51 -54 -52 -53 -53
Issuance of Debt
149 -173 551 246 106 125 93 81 158 108 94
Effect of Exchange Rate Changes
-6.00 -10 14 -26 7.00 14 - 3.00 -1.00 -1.00 -1.00

Annual Balance Sheets for Ingredion

This table presents Ingredion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,074 5,782 6,080 5,728 6,040 6,858 6,999 7,561 7,642 7,444 7,897
Total Current Assets
1,950 2,252 2,415 2,138 2,160 2,647 2,697 3,309 3,399 3,355 3,505
Cash & Equivalents
434 512 595 327 264 665 328 236 401 997 1,030
Short-Term Investments
6.00 4.00 9.00 7.00 4.00 0.00 4.00 3.00 8.00 11 3.00
Accounts Receivable
775 923 961 951 977 1,011 1,130 1,411 1,279 1,093 1,185
Inventories, net
715 789 823 824 861 917 1,172 1,597 1,450 1,187 1,227
Prepaid Expenses
20 24 27 29 54 54 63 62 261 67 60
Plant, Property, & Equipment, net
1,989 2,116 2,217 2,198 2,306 2,455 2,423 2,407 2,370 2,264 2,526
Total Noncurrent Assets
1,135 1,414 1,448 1,392 1,574 1,756 1,879 1,845 1,873 1,825 1,866
Goodwill
601 784 803 791 801 1,346 1,348 1,301 1,303 1,264 922
Intangible Assets
410 502 493 460 437 - - - - - 347
Other Noncurrent Operating Assets
117 121 143 131 323 410 531 544 570 561 597
Total Liabilities & Shareholders' Equity
5,074 5,782 6,080 5,728 6,040 6,858 6,999 7,561 7,642 7,444 7,897
Total Liabilities
2,894 3,157 3,127 3,283 3,268 3,786 3,774 4,299 3,992 3,554 3,531
Total Current Liabilities
742 978 957 946 967 1,458 1,512 1,882 1,772 1,281 1,316
Short-Term Debt
19 106 120 169 82 438 308 543 448 44 48
Accounts Payable
423 440 493 452 504 599 774 873 778 604 693
Other Current Liabilities
- - - - - - - 466 546 633 575
Total Noncurrent Liabilities
2,152 2,179 2,170 2,337 2,301 2,328 2,262 2,417 2,220 2,273 2,215
Long-Term Debt
1,989 2,008 1,971 1,931 1,766 2,328 2,262 2,417 2,220 2,273 2,215
Redeemable Noncontrolling Interest
- 30 36 37 31 100 107 99 98 67 71
Total Equity & Noncontrolling Interests
2,180 2,595 2,917 2,408 2,741 2,972 3,118 3,163 3,552 3,823 4,295
Total Preferred & Common Equity
2,144 2,565 2,891 2,388 2,720 2,951 3,100 3,147 3,538 3,804 4,274
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,144 2,565 2,891 2,388 2,720 2,951 3,100 3,147 3,538 3,804 4,274
Common Stock
1,161 1,150 1,139 1,097 1,138 1,151 1,159 1,133 1,147 1,153 1,156
Retained Earnings
2,552 2,899 3,259 3,536 3,780 3,957 3,899 4,210 4,654 5,092 5,610
Accumulated Other Comprehensive Income / (Loss)
-1,102 -1,071 -1,013 -1,154 -1,158 -1,133 -897 -1,048 -1,056 -1,086 -937
Other Equity Adjustments
-467 -413 -494 -1,091 -1,040 - -1,061 - -1,207 -1,355 -1,555
Noncontrolling Interest
36 30 26 20 21 21 18 16 14 19 21

Quarterly Balance Sheets for Ingredion

This table presents Ingredion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
7,600 7,549 7,319 7,221 7,525 7,468 7,781 7,833 7,928 8,070 8,127
Total Current Assets
3,311 3,289 3,125 3,099 3,351 3,365 3,517 3,516 3,525 3,523 3,560
Cash & Equivalents
257 335 438 505 877 837 861 915 914 948 989
Short-Term Investments
6.00 6.00 7.00 5.00 7.00 9.00 7.00 6.00 4.00 4.00 4.00
Accounts Receivable
1,366 1,380 1,284 1,286 1,173 1,284 1,359 1,312 1,358 1,386 1,346
Inventories, net
1,618 1,502 1,344 1,244 1,234 1,172 1,223 1,225 1,183 1,109 1,151
Prepaid Expenses
64 66 52 59 60 63 67 58 66 76 70
Plant, Property, & Equipment, net
2,414 2,401 2,334 2,291 2,332 2,289 2,361 2,435 2,561 2,521 2,560
Total Noncurrent Assets
1,875 1,859 1,860 1,831 1,842 1,814 1,903 1,882 1,842 2,026 2,007
Goodwill
1,311 1,296 1,286 1,275 1,295 1,264 1,280 1,273 920 917 917
Intangible Assets
- - - - - - - - 339 337 330
Other Noncurrent Operating Assets
564 563 574 556 547 550 623 609 583 772 760
Total Liabilities & Shareholders' Equity
7,600 7,549 7,319 7,221 7,525 7,468 7,781 7,833 7,928 8,070 8,127
Total Liabilities
4,125 4,082 3,494 3,442 3,495 3,420 3,505 3,509 3,482 3,497 3,518
Total Current Liabilities
1,720 1,668 1,283 1,230 1,255 1,182 1,264 1,278 1,277 1,259 1,774
Short-Term Debt
522 466 141 109 99 42 46 57 83 41 533
Accounts Payable
1,198 1,202 659 606 604 634 666 652 613 651 664
Other Current Liabilities
- - 483 515 552 506 552 569 581 567 577
Total Noncurrent Liabilities
2,405 2,414 2,211 2,212 2,240 2,238 2,241 2,231 2,205 2,238 1,744
Long-Term Debt
2,405 2,414 2,211 2,212 2,240 2,238 2,241 2,231 2,205 2,238 1,744
Redeemable Noncontrolling Interest
86 90 85 57 61 50 58 65 41 49 56
Total Equity & Noncontrolling Interests
3,389 3,377 3,740 3,722 3,969 3,998 4,218 4,259 4,405 4,524 4,553
Total Preferred & Common Equity
3,377 3,364 3,724 3,705 3,950 3,977 4,197 4,238 4,383 4,524 4,553
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,377 3,364 3,724 3,705 3,950 3,977 4,197 4,238 4,383 4,524 4,553
Common Stock
1,143 1,144 1,147 1,142 1,146 1,159 1,161 1,157 1,163 1,164 1,148
Retained Earnings
4,469 4,575 4,818 4,914 5,049 5,236 5,380 5,497 5,700 5,761 5,851
Treasury Stock
- - - -1,233 - - - - - - -1,624
Accumulated Other Comprehensive Income / (Loss)
-1,119 -1,144 -1,062 -1,118 -1,000 -1,025 -953 -950 -927 -848 -822
Noncontrolling Interest
12 13 16 17 19 21 21 21 22 0.00 0.00

Annual Metrics And Ratios for Ingredion

This table displays calculated financial ratios and metrics derived from Ingredion's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.83% 1.48% 9.47% 0.72% -1.27% -3.58% 15.15% 15.26% 2.69% -8.95% -2.84%
EBITDA Growth
10.05% 17.56% 4.68% -9.23% -7.44% -9.40% -32.25% 81.18% 19.35% 1.02% 4.14%
EBIT Growth
13.60% 22.42% 4.21% -16.03% -6.22% -11.46% -45.14% 138.20% 24.25% 1.78% 4.23%
NOPAT Growth
11.93% 18.69% 7.34% -11.14% -5.88% -15.83% -61.63% 266.49% 29.67% -16.47% 23.77%
Net Income Growth
13.50% 20.39% 7.26% -14.66% -6.61% -16.51% -64.69% 301.60% 29.68% 0.46% 12.54%
EPS Growth
16.24% 18.87% 7.79% -12.61% -0.65% -15.99% -66.41% 324.28% 30.79% 1.15% 15.14%
Operating Cash Flow Growth
-6.16% 12.39% -0.26% -8.58% -3.27% 21.91% -52.71% -61.22% 595.39% 35.86% -34.26%
Free Cash Flow Firm Growth
-43.31% -76.97% 466.54% 105.60% -53.87% -220.74% 67.68% 139.36% 1,451.19% 62.91% -72.13%
Invested Capital Growth
4.96% 12.67% 5.14% -5.16% 3.35% 18.86% 5.61% 9.52% -1.24% -12.02% 7.64%
Revenue Q/Q Growth
2.09% -0.09% 7.75% 0.40% -4.97% 0.74% 2.41% 3.01% -0.80% -1.60% -0.59%
EBITDA Q/Q Growth
6.88% 1.83% 2.34% -3.83% 1.61% -1.11% -10.12% 5.82% 3.81% -3.35% 4.94%
EBIT Q/Q Growth
8.91% 2.15% 2.56% -5.86% 1.69% -0.34% -18.07% 9.10% 4.84% -4.06% 5.75%
NOPAT Q/Q Growth
11.80% -2.14% 0.85% 0.21% 3.47% 1.23% -26.95% 13.29% 1.23% -6.99% 10.58%
Net Income Q/Q Growth
12.02% -1.98% 1.14% -1.30% 3.92% 0.85% -27.75% 10.33% 2.84% -5.22% 10.51%
EPS Q/Q Growth
11.76% -2.09% 1.00% 0.65% 4.07% 1.58% -28.22% 10.38% 2.78% -5.27% 11.47%
Operating Cash Flow Q/Q Growth
-8.53% 3.21% 2.12% -14.68% 10.75% 10.24% -25.48% -28.64% 47.01% 1.84% -3.18%
Free Cash Flow Firm Q/Q Growth
132.62% -88.29% 14,557.88% 22.83% -37.29% -325.87% 33.82% 111.74% 37.81% 11.99% -24.07%
Invested Capital Q/Q Growth
-3.03% 9.09% -0.16% -3.31% 1.78% 15.08% 11.24% 2.01% -1.62% -5.21% -1.67%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
22.10% 24.56% 23.57% 21.75% 21.13% 21.25% 19.31% 18.80% 21.43% 24.11% 25.32%
EBITDA Margin
15.19% 17.60% 16.83% 15.17% 14.22% 13.36% 7.86% 12.36% 14.36% 15.94% 17.08%
Operating Margin
11.74% 14.13% 13.39% 11.18% 10.69% 9.72% 4.50% 9.59% 11.73% 11.88% 14.07%
EBIT Margin
11.74% 14.17% 13.48% 11.24% 10.68% 9.80% 4.67% 9.65% 11.68% 13.06% 14.00%
Profit (Net Income) Margin
7.33% 8.70% 8.52% 7.22% 6.83% 5.91% 1.81% 6.32% 7.98% 8.80% 10.20%
Tax Burden Percent
68.78% 66.85% 69.18% 73.11% 72.85% 69.96% 50.40% 75.15% 77.59% 70.25% 75.56%
Interest Burden Percent
90.76% 91.83% 91.33% 87.84% 87.78% 86.20% 77.02% 87.09% 88.04% 95.98% 96.34%
Effective Tax Rate
31.22% 33.15% 30.82% 26.89% 27.15% 30.04% 49.60% 24.85% 22.41% 29.75% 24.44%
Return on Invested Capital (ROIC)
12.40% 13.52% 13.35% 11.88% 11.30% 8.55% 2.94% 10.01% 12.49% 11.17% 14.22%
ROIC Less NNEP Spread (ROIC-NNEP)
9.54% 10.82% 10.35% 8.20% 7.73% 5.66% 1.50% 7.16% 8.81% 13.06% 11.72%
Return on Net Nonoperating Assets (RNNOA)
6.38% 7.13% 5.72% 4.94% 4.96% 3.57% 1.03% 5.47% 6.35% 6.18% 3.61%
Return on Equity (ROE)
18.78% 20.65% 19.07% 16.82% 16.25% 12.12% 3.97% 15.48% 18.84% 17.35% 17.83%
Cash Return on Invested Capital (CROIC)
7.57% 1.60% 8.34% 17.18% 8.01% -8.69% -2.52% 0.92% 13.73% 23.95% 6.87%
Operating Return on Assets (OROA)
12.99% 14.89% 14.20% 11.97% 11.27% 9.10% 4.65% 10.54% 12.54% 12.86% 13.18%
Return on Assets (ROA)
8.11% 9.14% 8.97% 7.69% 7.21% 5.49% 1.80% 6.90% 8.56% 8.67% 9.60%
Return on Common Equity (ROCE)
18.50% 20.23% 18.66% 16.45% 15.91% 11.76% 3.82% 14.90% 18.22% 16.89% 17.45%
Return on Equity Simple (ROE_SIMPLE)
19.22% 19.34% 18.40% 19.01% 15.59% 12.00% 4.03% 15.95% 18.40% 17.19% 0.00%
Net Operating Profit after Tax (NOPAT)
454 539 578 514 484 407 156 573 743 620 768
NOPAT Margin
8.08% 9.45% 9.26% 8.17% 7.79% 6.80% 2.27% 7.21% 9.10% 8.35% 10.64%
Net Nonoperating Expense Percent (NNEP)
2.86% 2.70% 3.00% 3.69% 3.57% 2.89% 1.44% 2.85% 3.68% -1.89% 2.50%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.35% 11.94% 10.10% 11.71%
Cost of Revenue to Revenue
77.90% 75.44% 76.43% 78.25% 78.87% 78.75% 80.69% 81.20% 78.57% 75.90% 74.68%
SG&A Expenses to Revenue
0.00% 0.00% 9.87% 9.72% 9.82% 10.49% 9.69% 9.00% 9.67% 10.52% 11.29%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.35% 10.43% 10.19% 10.57% 10.44% 11.53% 14.81% 9.21% 9.71% 12.22% 11.25%
Earnings before Interest and Taxes (EBIT)
660 808 842 707 663 587 322 767 953 970 1,011
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
854 1,004 1,051 954 883 800 542 982 1,172 1,184 1,233
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.57 2.88 2.89 2.30 2.00 1.61 1.93 1.93 1.95 2.34 1.63
Price to Tangible Book Value (P/TBV)
4.86 5.77 5.23 4.83 3.66 2.97 3.41 3.29 3.09 3.51 2.31
Price to Revenue (P/Rev)
0.98 1.29 1.34 0.87 0.87 0.80 0.87 0.77 0.85 1.20 0.96
Price to Earnings (P/E)
13.70 15.22 16.07 12.39 13.14 13.69 51.09 12.36 10.73 13.77 9.54
Dividend Yield
2.26% 1.86% 1.90% 3.15% 3.09% 3.57% 2.87% 2.93% 2.82% 2.30% 2.94%
Earnings Yield
7.30% 6.57% 6.22% 8.07% 7.61% 7.31% 1.96% 8.09% 9.32% 7.26% 10.49%
Enterprise Value to Invested Capital (EV/IC)
1.90 2.14 2.23 1.74 1.62 1.35 1.53 1.49 1.57 1.98 1.48
Enterprise Value to Revenue (EV/Rev)
1.27 1.58 1.58 1.16 1.14 1.17 1.21 1.12 1.14 1.39 1.15
Enterprise Value to EBITDA (EV/EBITDA)
8.33 9.00 9.41 7.67 8.00 8.73 15.39 9.08 7.91 8.70 6.71
Enterprise Value to EBIT (EV/EBIT)
10.77 11.19 11.75 10.34 10.65 11.90 25.90 11.63 9.73 10.62 8.18
Enterprise Value to NOPAT (EV/NOPAT)
15.66 16.78 17.10 14.23 14.60 17.16 53.38 15.57 12.49 16.62 10.78
Enterprise Value to Operating Cash Flow (EV/OCF)
10.36 11.72 12.86 10.40 10.38 8.43 21.28 58.67 8.77 7.18 8.77
Enterprise Value to Free Cash Flow (EV/FCFF)
25.67 141.72 27.37 9.84 20.60 0.00 0.00 169.41 11.35 7.75 22.32
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.92 0.81 0.71 0.86 0.67 0.90 0.80 0.91 0.73 0.60 0.52
Long-Term Debt to Equity
0.91 0.77 0.67 0.79 0.64 0.76 0.70 0.74 0.61 0.58 0.51
Financial Leverage
0.67 0.66 0.55 0.60 0.64 0.63 0.69 0.76 0.72 0.47 0.31
Leverage Ratio
2.32 2.26 2.13 2.19 2.26 2.21 2.20 2.24 2.20 2.00 1.86
Compound Leverage Factor
2.10 2.07 1.94 1.92 1.98 1.90 1.69 1.95 1.94 1.92 1.79
Debt to Total Capital
47.95% 44.61% 41.46% 46.20% 40.00% 47.38% 44.35% 47.57% 42.23% 37.33% 34.14%
Short-Term Debt to Total Capital
0.45% 2.24% 2.38% 3.72% 1.77% 7.50% 5.31% 8.73% 7.09% 0.71% 0.72%
Long-Term Debt to Total Capital
47.49% 42.37% 39.08% 42.49% 38.23% 39.88% 39.03% 38.85% 35.14% 36.62% 33.41%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.86% 1.27% 1.23% 1.25% 1.13% 2.07% 2.16% 1.85% 1.77% 1.39% 1.39%
Common Equity to Total Capital
51.19% 54.13% 57.32% 52.54% 58.87% 50.55% 53.49% 50.58% 56.00% 61.29% 64.47%
Debt to EBITDA
2.35 2.11 1.99 2.20 2.09 3.46 4.74 3.01 2.28 1.96 1.84
Net Debt to EBITDA
1.84 1.59 1.41 1.85 1.79 2.63 4.13 2.77 1.93 1.11 1.00
Long-Term Debt to EBITDA
2.33 2.00 1.88 2.02 2.00 2.91 4.17 2.46 1.89 1.92 1.80
Debt to NOPAT
4.42 3.92 3.62 4.09 3.82 6.79 16.45 5.17 3.59 3.74 2.95
Net Debt to NOPAT
3.45 2.97 2.57 3.44 3.27 5.16 14.32 4.75 3.04 2.11 1.60
Long-Term Debt to NOPAT
4.38 3.73 3.41 3.76 3.65 5.72 14.48 4.22 2.99 3.66 2.89
Altman Z-Score
3.67 3.82 4.12 3.62 3.50 2.93 3.07 3.24 3.62 4.22 3.85
Noncontrolling Interest Sharing Ratio
1.50% 2.00% 2.19% 2.20% 2.09% 2.96% 3.91% 3.70% 3.28% 2.63% 2.16%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.63 2.30 2.52 2.26 2.23 1.82 1.78 1.76 1.92 2.62 2.66
Quick Ratio
1.64 1.47 1.64 1.36 1.29 1.15 0.97 0.88 0.95 1.64 1.69
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
277 64 361 743 343 -414 -134 53 817 1,330 371
Operating Cash Flow to CapEx
283.47% 274.38% 251.31% 201.43% 208.59% 248.95% 139.01% 51.88% 336.62% 486.78% 218.01%
Free Cash Flow to Firm to Interest Expense
4.54 0.97 4.95 8.64 4.23 -5.11 -1.81 0.53 7.16 34.11 10.02
Operating Cash Flow to Interest Expense
11.25 11.68 10.53 8.17 8.40 10.23 5.30 1.54 9.27 36.82 25.51
Operating Cash Flow Less CapEx to Interest Expense
7.28 7.42 6.34 4.12 4.37 6.12 1.49 -1.42 6.52 29.26 13.81
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.11 1.05 1.05 1.07 1.06 0.93 1.00 1.09 1.07 0.99 0.94
Accounts Receivable Turnover
7.31 6.72 6.63 6.58 6.44 6.02 6.44 6.25 6.07 6.26 6.34
Inventory Turnover
6.19 5.72 5.92 5.98 5.81 5.30 5.33 4.66 4.21 4.28 4.47
Fixed Asset Turnover
2.77 2.78 2.88 2.85 2.76 2.52 2.83 3.29 3.42 3.21 3.01
Accounts Payable Turnover
10.27 9.97 10.23 10.41 10.24 8.55 8.10 7.83 7.77 8.16 8.31
Days Sales Outstanding (DSO)
49.90 54.33 55.07 55.48 56.67 60.60 56.68 58.36 60.16 58.26 57.59
Days Inventory Outstanding (DIO)
58.93 63.79 61.65 61.08 62.80 68.82 68.53 78.32 86.74 85.34 81.72
Days Payable Outstanding (DPO)
35.55 36.60 35.68 35.05 35.63 42.69 45.04 46.59 47.00 44.73 43.91
Cash Conversion Cycle (CCC)
73.28 81.51 81.03 81.52 83.84 86.73 80.17 90.10 99.90 98.88 95.40
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,748 4,223 4,440 4,211 4,352 5,173 5,463 5,983 5,909 5,199 5,596
Invested Capital Turnover
1.54 1.43 1.44 1.45 1.45 1.26 1.30 1.39 1.37 1.34 1.34
Increase / (Decrease) in Invested Capital
177 475 217 -229 141 821 290 520 -74 -710 397
Enterprise Value (EV)
7,110 9,039 9,891 7,314 7,060 6,985 8,341 8,918 9,271 10,306 8,275
Market Capitalization
5,506 7,381 8,342 5,491 5,428 4,763 5,978 6,082 6,900 8,911 6,953
Book Value per Share
$29.97 $35.43 $40.23 $33.77 $40.74 $44.05 $46.59 $48.01 $54.27 $58.38 $67.28
Tangible Book Value per Share
$15.84 $17.67 $22.19 $16.08 $22.20 $23.96 $26.33 $28.16 $34.28 $38.98 $47.30
Total Capital
4,188 4,739 5,044 4,545 4,620 5,838 5,795 6,222 6,318 6,207 6,629
Total Debt
2,008 2,114 2,091 2,100 1,848 2,766 2,570 2,960 2,668 2,317 2,263
Total Long-Term Debt
1,989 2,008 1,971 1,931 1,766 2,328 2,262 2,417 2,220 2,273 2,215
Net Debt
1,568 1,598 1,487 1,766 1,580 2,101 2,238 2,721 2,259 1,309 1,230
Capital Expenditures (CapEx)
242 281 306 349 326 333 282 293 314 295 433
Debt-free, Cash-free Net Working Capital (DFCFNWC)
787 864 974 1,027 1,007 962 1,161 1,731 1,666 1,110 1,204
Debt-free Net Working Capital (DFNWC)
1,227 1,380 1,578 1,361 1,275 1,627 1,493 1,970 2,075 2,118 2,237
Net Working Capital (NWC)
1,208 1,274 1,458 1,192 1,193 1,189 1,185 1,427 1,627 2,074 2,189
Net Nonoperating Expense (NNE)
42 43 46 60 60 53 31 71 92 -34 32
Net Nonoperating Obligations (NNO)
1,568 1,598 1,487 1,766 1,580 2,101 2,238 2,721 2,259 1,309 1,230
Total Depreciation and Amortization (D&A)
194 196 209 247 220 213 220 215 219 214 222
Debt-free, Cash-free Net Working Capital to Revenue
14.00% 15.15% 15.60% 16.33% 16.22% 16.07% 16.84% 21.78% 20.42% 14.94% 16.68%
Debt-free Net Working Capital to Revenue
21.83% 24.19% 25.27% 21.64% 20.53% 27.18% 21.66% 24.79% 25.43% 28.51% 30.99%
Net Working Capital to Revenue
21.49% 22.34% 23.35% 18.95% 19.21% 19.86% 17.19% 17.96% 19.94% 27.91% 30.32%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$5.62 $6.70 $7.21 $6.25 $6.17 $5.18 $1.74 $7.43 $9.74 $9.88 $11.36
Adjusted Weighted Average Basic Shares Outstanding
71.60M 72.30M 72M 70.90M 66.90M 67.20M 67.10M 66.20M 66M 65.50M 64.20M
Adjusted Diluted Earnings per Share
$5.51 $6.55 $7.06 $6.17 $6.13 $5.15 $1.73 $7.34 $9.60 $9.71 $11.18
Adjusted Weighted Average Diluted Shares Outstanding
73M 74.10M 73.50M 71.80M 67.40M 67.60M 67.80M 67M 67M 66.60M 65.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
71.89M 71.79M 72.24M 66.67M 66.88M 67.11M 66.71M 65.95M 65.56M 64.19M 62.95M
Normalized Net Operating Profit after Tax (NOPAT)
855 939 605 561 525 472 351 576 751 709 784
Normalized NOPAT Margin
15.21% 16.47% 9.68% 8.92% 8.46% 7.89% 5.10% 7.24% 9.20% 9.55% 10.85%
Pre Tax Income Margin
10.66% 13.01% 12.32% 9.87% 9.37% 8.45% 3.60% 8.41% 10.28% 12.53% 13.49%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.82 12.24 11.53 8.22 8.19 7.25 4.35 7.75 8.36 24.87 27.32
NOPAT to Interest Expense
7.44 8.16 7.92 5.98 5.97 5.03 2.11 5.78 6.51 15.90 20.75
EBIT Less CapEx to Interest Expense
6.85 7.98 7.34 4.16 4.16 3.14 0.54 4.79 5.61 17.31 15.62
NOPAT Less CapEx to Interest Expense
3.47 3.91 3.73 1.92 1.95 0.92 -1.70 2.82 3.76 8.34 9.05
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
30.58% -28.43% 31.02% 40.09% 41.04% 50.28% 147.20% 36.06% 29.80% 32.11% 28.67%
Augmented Payout Ratio
40.53% -26.81% 54.14% 184.80% 25.47% 50.28% 201.60% 67.53% 45.62% 71.25% 59.10%

Quarterly Metrics And Ratios for Ingredion

This table displays calculated financial ratios and metrics derived from Ingredion's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 62,945,041.00 63,059,061.00 63,063,979.00
DEI Adjusted Shares Outstanding
- - - - - - - - 62,945,041.00 63,059,061.00 63,063,979.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 2.26 1.81 2.25
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-11.93% -9.23% -8.02% -6.30% -3.67% -2.40% -2.89% -2.39% -1.16% 0.93% -1.32%
EBITDA Growth
0.87% -3.29% 22.47% -16.02% -4.89% 10.20% -6.73% 26.98% -22.05% -12.04% -16.72%
EBIT Growth
1.37% -3.61% 29.86% -20.30% -6.44% 12.92% -9.49% 34.16% -26.45% -15.13% -19.76%
NOPAT Growth
-22.82% -16.73% 0.72% -32.27% 22.27% 32.36% -4.22% 71.68% -26.75% -39.85% -17.21%
Net Income Growth
12.37% -8.54% 18.13% -27.07% -8.72% 32.00% -8.99% 72.16% -27.64% -41.41% -17.44%
EPS Growth
13.33% -8.26% 19.92% -27.41% -7.12% 34.68% -7.77% 80.42% -26.00% -40.47% -14.56%
Operating Cash Flow Growth
509.80% -5.45% 30.16% 6.34% -63.16% -40.71% -42.17% -7.11% -57.14% -51.35% -3.97%
Free Cash Flow Firm Growth
676.78% 1,015.83% 1,534.89% 258.87% -31.91% -85.52% -104.00% -126.99% -140.23% -178.67% -93.97%
Invested Capital Growth
-8.04% -8.94% -8.67% -12.02% -4.36% 1.88% 3.76% 7.64% 6.09% 3.60% 3.55%
Revenue Q/Q Growth
-2.03% -0.21% -0.43% -3.74% 0.72% 1.10% -0.93% -3.25% 1.99% 3.24% -3.14%
EBITDA Q/Q Growth
35.94% -15.52% 11.22% -34.25% 53.95% -2.11% -5.86% -10.49% -5.49% 10.47% -10.88%
EBIT Q/Q Growth
46.04% -18.64% 14.17% -41.24% 71.43% -1.81% -8.49% -12.90% -6.02% 13.30% -13.48%
NOPAT Q/Q Growth
10.21% -6.96% 18.54% -44.28% 98.98% 0.71% -14.22% -0.12% -15.10% -17.30% 18.06%
Net Income Q/Q Growth
63.91% -31.19% 26.00% -48.68% 105.15% -0.50% -13.13% -2.91% -13.77% -19.44% 22.41%
EPS Q/Q Growth
63.96% -31.27% 27.48% -49.47% 109.79% -0.33% -12.71% -1.15% -13.95% -19.82% 25.28%
Operating Cash Flow Q/Q Growth
-49.02% 49.28% 53.53% -8.98% -82.34% 140.26% 49.73% 46.21% -91.85% 172.73% 195.56%
Free Cash Flow Firm Q/Q Growth
195.28% 5.42% 0.14% 15.12% -43.97% -77.58% -127.69% -675.92% 16.49% 56.15% 31.73%
Invested Capital Q/Q Growth
-3.00% -2.48% -1.88% -5.21% 5.44% 3.89% -0.07% -1.67% 3.93% 1.44% -0.12%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
22.16% 23.75% 25.62% 24.94% 25.70% 26.02% 25.06% 24.47% 22.38% 23.03% 22.27%
EBITDA Margin
18.49% 15.66% 17.49% 11.94% 18.26% 17.68% 16.80% 15.54% 14.40% 15.41% 14.17%
Operating Margin
11.32% 12.78% 14.33% 9.00% 15.22% 14.78% 13.71% 12.52% 11.33% 10.16% 11.22%
EBIT Margin
15.67% 12.78% 14.65% 8.94% 15.22% 14.78% 13.66% 12.29% 11.33% 12.43% 11.10%
Profit (Net Income) Margin
11.58% 7.99% 10.11% 5.39% 10.98% 10.80% 9.47% 9.50% 8.04% 6.27% 7.92%
Tax Burden Percent
78.99% 65.22% 69.23% 63.82% 74.53% 76.45% 71.37% 80.68% 74.23% 66.29% 73.20%
Interest Burden Percent
93.56% 95.83% 99.64% 94.41% 96.74% 95.57% 97.18% 95.83% 95.57% 76.09% 97.49%
Effective Tax Rate
21.01% 34.78% 30.77% 36.18% 25.47% 23.55% 28.63% 19.32% 25.77% 33.71% 26.80%
Return on Invested Capital (ROIC)
11.81% 10.96% 13.04% 7.68% 14.90% 14.65% 12.72% 13.51% 10.71% 8.38% 10.19%
ROIC Less NNEP Spread (ROIC-NNEP)
13.90% 10.67% 13.21% 7.33% 14.49% 14.09% 12.31% 12.68% 10.24% 7.76% 9.81%
Return on Net Nonoperating Assets (RNNOA)
9.23% 6.58% 7.04% 3.47% 6.15% 5.65% 4.16% 3.90% 3.38% 2.41% 2.91%
Return on Equity (ROE)
21.04% 17.55% 20.08% 11.15% 21.05% 20.30% 16.88% 17.41% 14.09% 10.79% 13.10%
Cash Return on Invested Capital (CROIC)
19.96% 20.65% 20.68% 23.95% 16.08% 10.57% 8.74% 6.87% 6.70% 7.34% 6.87%
Operating Return on Assets (OROA)
16.56% 13.30% 14.68% 8.81% 15.16% 14.42% 12.91% 11.57% 10.59% 11.32% 10.01%
Return on Assets (ROA)
12.24% 8.31% 10.13% 5.31% 10.93% 10.54% 8.96% 8.95% 7.51% 5.71% 7.14%
Return on Common Equity (ROCE)
20.45% 17.13% 19.59% 10.86% 20.59% 19.92% 16.54% 17.04% 13.87% 10.63% 12.90%
Return on Equity Simple (ROE_SIMPLE)
18.13% 17.84% 17.47% 0.00% 15.97% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
168 157 186 103 206 207 178 177 151 125 147
NOPAT Margin
8.94% 8.33% 9.92% 5.74% 11.35% 11.30% 9.79% 10.10% 8.41% 6.74% 8.21%
Net Nonoperating Expense Percent (NNEP)
-2.08% 0.29% -0.17% 0.36% 0.40% 0.57% 0.40% 0.83% 0.48% 0.63% 0.39%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.68% 3.28% 3.18% 2.71% 2.71% 2.25% 1.83% 2.15%
Cost of Revenue to Revenue
77.84% 76.25% 74.39% 75.06% 74.30% 73.98% 74.94% 75.53% 77.62% 76.97% 77.73%
SG&A Expenses to Revenue
10.04% 10.17% 10.59% 11.33% 10.65% 11.35% 11.18% 12.01% 11.16% 11.19% 12.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.84% 10.97% 11.28% 15.94% 10.48% 11.24% 11.34% 11.95% 11.05% 12.86% 11.05%
Earnings before Interest and Taxes (EBIT)
295 240 274 161 276 271 248 216 203 230 199
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
348 294 327 215 331 324 305 273 258 285 254
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.03 2.02 2.25 2.34 2.17 2.07 1.84 1.63 1.61 1.31 1.32
Price to Tangible Book Value (P/TBV)
3.10 3.08 3.35 3.51 3.18 2.97 2.63 2.31 2.25 1.81 1.81
Price to Revenue (P/Rev)
0.96 0.97 1.18 1.20 1.17 1.19 1.07 0.96 0.98 0.82 0.83
Price to Earnings (P/E)
11.33 11.45 13.02 13.77 13.74 12.83 11.81 9.54 10.44 10.00 10.64
Dividend Yield
2.63% 2.68% 2.28% 2.30% 2.35% 2.36% 2.64% 2.94% 2.90% 3.47% 3.45%
Earnings Yield
8.83% 8.73% 7.68% 7.26% 7.28% 7.80% 8.47% 10.49% 9.57% 10.00% 9.40%
Enterprise Value to Invested Capital (EV/IC)
1.67 1.68 1.90 1.98 1.85 1.79 1.62 1.48 1.46 1.24 1.24
Enterprise Value to Revenue (EV/Rev)
1.21 1.21 1.38 1.39 1.38 1.39 1.27 1.15 1.18 1.01 1.02
Enterprise Value to EBITDA (EV/EBITDA)
8.15 8.04 8.51 8.70 8.68 8.49 7.86 6.71 7.27 6.73 7.09
Enterprise Value to EBIT (EV/EBIT)
10.00 9.88 10.31 10.62 10.65 10.35 9.66 8.18 8.98 8.48 9.03
Enterprise Value to NOPAT (EV/NOPAT)
13.81 14.15 15.63 16.62 15.55 14.49 13.31 10.78 11.89 11.57 12.22
Enterprise Value to Operating Cash Flow (EV/OCF)
7.27 7.21 7.39 7.18 7.77 8.64 9.47 8.77 9.41 9.06 9.23
Enterprise Value to Free Cash Flow (EV/FCFF)
8.02 7.73 8.78 7.75 11.24 17.04 18.92 22.32 22.37 17.15 18.41
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.61 0.61 0.58 0.60 0.56 0.53 0.53 0.52 0.51 0.50 0.49
Long-Term Debt to Equity
0.58 0.59 0.56 0.58 0.55 0.52 0.52 0.51 0.50 0.49 0.38
Financial Leverage
0.66 0.62 0.53 0.47 0.42 0.40 0.34 0.31 0.33 0.31 0.30
Leverage Ratio
2.08 2.04 2.01 2.00 1.88 1.86 1.84 1.86 1.81 1.79 1.79
Compound Leverage Factor
1.95 1.96 2.00 1.89 1.82 1.78 1.79 1.78 1.73 1.36 1.74
Debt to Total Capital
38.08% 38.05% 36.72% 37.33% 36.03% 34.85% 34.60% 34.14% 33.98% 33.26% 33.07%
Short-Term Debt to Total Capital
2.28% 1.79% 1.55% 0.71% 0.66% 0.70% 0.86% 0.72% 1.23% 0.60% 7.74%
Long-Term Debt to Total Capital
35.79% 36.26% 35.17% 36.62% 35.37% 34.15% 33.74% 33.41% 32.74% 32.66% 25.33%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.64% 1.21% 1.26% 1.39% 1.12% 1.20% 1.30% 1.39% 0.94% 0.72% 0.81%
Common Equity to Total Capital
60.29% 60.74% 62.02% 61.29% 62.85% 63.95% 64.10% 64.47% 65.09% 66.02% 66.12%
Debt to EBITDA
2.00 1.99 1.91 1.96 1.95 1.91 1.95 1.84 1.96 2.10 2.20
Net Debt to EBITDA
1.62 1.55 1.19 1.11 1.23 1.19 1.16 1.00 1.18 1.22 1.24
Long-Term Debt to EBITDA
1.88 1.90 1.83 1.92 1.92 1.87 1.90 1.80 1.89 2.06 1.69
Debt to NOPAT
3.39 3.51 3.51 3.74 3.50 3.26 3.30 2.95 3.21 3.61 3.79
Net Debt to NOPAT
2.75 2.74 2.18 2.11 2.20 2.02 1.97 1.60 1.92 2.10 2.14
Long-Term Debt to NOPAT
3.19 3.34 3.36 3.66 3.44 3.19 3.21 2.89 3.09 3.55 2.91
Altman Z-Score
3.74 3.74 3.92 3.87 3.95 3.85 3.69 3.51 3.55 3.34 3.26
Noncontrolling Interest Sharing Ratio
2.82% 2.37% 2.44% 2.63% 2.18% 1.90% 1.99% 2.16% 1.58% 1.45% 1.59%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.44 2.52 2.67 2.62 2.85 2.78 2.75 2.66 2.76 2.80 2.01
Quick Ratio
1.35 1.46 1.64 1.64 1.80 1.76 1.75 1.69 1.78 1.86 1.32
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
669 706 707 813 456 102 -28 -220 -183 -80 -55
Operating Cash Flow to CapEx
321.54% 567.27% 958.00% 348.80% 83.70% 183.17% 263.81% 300.00% 30.00% 90.00% 258.25%
Free Cash Flow to Firm to Interest Expense
35.22 70.55 706.54 90.38 50.63 8.51 -4.04 -24.39 -20.37 -1.46 -10.98
Operating Cash Flow to Interest Expense
11.00 31.20 479.00 48.44 8.56 15.42 39.57 45.00 3.67 1.64 53.20
Operating Cash Flow Less CapEx to Interest Expense
7.58 25.70 429.00 34.56 -1.67 7.00 24.57 30.00 -8.56 -0.18 32.60
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.06 1.04 1.00 0.99 1.00 0.98 0.95 0.94 0.94 0.91 0.90
Accounts Receivable Turnover
5.77 5.82 5.92 6.26 5.73 5.53 5.84 6.34 5.45 5.26 5.41
Inventory Turnover
4.14 4.21 4.25 4.28 4.39 4.41 4.40 4.47 4.62 4.72 4.66
Fixed Asset Turnover
3.34 3.28 3.19 3.21 3.18 3.15 3.05 3.01 2.97 2.96 2.88
Accounts Payable Turnover
6.73 6.69 6.43 8.16 8.54 8.56 8.62 8.31 8.72 8.36 8.41
Days Sales Outstanding (DSO)
63.23 62.74 61.70 58.26 63.67 65.98 62.45 57.59 66.99 69.43 67.46
Days Inventory Outstanding (DIO)
88.14 86.62 85.96 85.34 83.17 82.69 82.87 81.72 79.08 77.34 78.34
Days Payable Outstanding (DPO)
54.23 54.60 56.74 44.73 42.74 42.63 42.33 43.91 41.87 43.68 43.39
Cash Conversion Cycle (CCC)
97.15 94.76 90.92 98.88 104.10 106.03 102.99 95.40 104.19 103.09 102.41
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,732 5,590 5,485 5,199 5,482 5,695 5,691 5,596 5,816 5,900 5,893
Invested Capital Turnover
1.32 1.32 1.31 1.34 1.31 1.30 1.30 1.34 1.27 1.24 1.24
Increase / (Decrease) in Invested Capital
-501 -549 -521 -710 -250 105 206 397 334 205 202
Enterprise Value (EV)
9,574 9,364 10,424 10,306 10,132 10,168 9,238 8,275 8,473 7,297 7,330
Market Capitalization
7,566 7,479 8,889 8,911 8,627 8,670 7,785 6,953 7,040 5,921 5,990
Book Value per Share
$56.68 $56.44 $60.71 $58.38 $61.96 $65.26 $66.03 $67.28 $69.63 $71.74 $72.20
Tangible Book Value per Share
$37.11 $37.02 $40.81 $38.98 $42.27 $45.36 $46.20 $47.30 $49.63 $51.86 $52.42
Total Capital
6,177 6,100 6,369 6,207 6,328 6,563 6,612 6,629 6,734 6,852 6,886
Total Debt
2,352 2,321 2,339 2,317 2,280 2,287 2,288 2,263 2,288 2,279 2,277
Total Long-Term Debt
2,211 2,212 2,240 2,273 2,238 2,241 2,231 2,215 2,205 2,238 1,744
Net Debt
1,907 1,811 1,455 1,309 1,434 1,419 1,367 1,230 1,370 1,327 1,284
Capital Expenditures (CapEx)
65 55 50 125 92 101 105 135 110 100 103
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,538 1,468 1,311 1,110 1,379 1,431 1,374 1,204 1,413 1,353 1,326
Debt-free Net Working Capital (DFNWC)
1,983 1,978 2,195 2,118 2,225 2,299 2,295 2,237 2,331 2,305 2,319
Net Working Capital (NWC)
1,842 1,869 2,096 2,074 2,183 2,253 2,238 2,189 2,248 2,264 1,786
Net Nonoperating Expense (NNE)
-50 6.52 -3.46 6.38 6.71 9.17 5.71 10 6.68 8.62 5.12
Net Nonoperating Obligations (NNO)
1,907 1,811 1,455 1,309 1,434 1,419 1,367 1,230 1,370 1,327 1,284
Total Depreciation and Amortization (D&A)
53 54 53 54 55 53 57 57 55 55 55
Debt-free, Cash-free Net Working Capital to Revenue
19.46% 19.03% 17.36% 14.94% 18.73% 19.56% 18.92% 16.68% 19.63% 18.75% 18.44%
Debt-free Net Working Capital to Revenue
25.09% 25.64% 29.07% 28.51% 30.23% 31.42% 31.60% 30.99% 32.38% 31.95% 32.25%
Net Working Capital to Revenue
23.30% 24.23% 27.76% 27.91% 29.66% 30.80% 30.82% 30.32% 31.23% 31.38% 24.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.29 $2.25 $2.88 $1.46 $3.05 $3.04 $2.66 $2.61 $2.25 $1.80 $2.25
Adjusted Weighted Average Basic Shares Outstanding
65.70M 65.70M 65.30M 65.50M 64.50M 64.50M 64.30M 64.20M 63.20M 63.30M 63.10M
Adjusted Diluted Earnings per Share
$3.23 $2.22 $2.83 $1.43 $3.00 $2.99 $2.61 $2.58 $2.22 $1.78 $2.23
Adjusted Weighted Average Diluted Shares Outstanding
66.80M 66.80M 66.50M 66.60M 65.60M 65.60M 65.40M 65.20M 64M 63.90M 63.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
65.65M 65.06M 65.16M 64.19M 64.31M 64.18M 63.53M 62.95M 63.06M 63.06M 62.29M
Normalized Net Operating Profit after Tax (NOPAT)
171 172 194 160 211 209 180 184 159 154 137
Normalized NOPAT Margin
9.07% 9.13% 10.37% 8.90% 11.63% 11.43% 9.90% 10.47% 8.86% 8.35% 7.64%
Pre Tax Income Margin
14.67% 12.25% 14.60% 8.44% 14.73% 14.13% 13.27% 11.78% 10.83% 9.46% 10.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
15.53 24.00 274.00 17.89 30.67 22.58 35.43 24.00 22.56 4.18 39.80
NOPAT to Interest Expense
8.85 15.65 185.54 11.49 22.86 17.26 25.39 19.72 16.74 2.27 29.42
EBIT Less CapEx to Interest Expense
12.11 18.50 224.00 4.00 20.44 14.17 20.43 9.00 10.33 2.36 19.20
NOPAT Less CapEx to Interest Expense
5.43 10.15 135.54 -2.40 12.63 8.85 10.39 4.72 4.52 0.45 8.82
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
29.33% 30.71% 30.00% 32.11% 33.23% 31.04% 31.68% 28.67% 30.98% 35.06% 37.26%
Augmented Payout Ratio
44.74% 62.33% 48.41% 71.25% 82.05% 61.05% 71.17% 59.10% 58.88% 66.78% 73.99%

Financials Breakdown Chart

Key Financial Trends

Ingredion’s latest financial statements show a mixed picture. Revenue improved modestly in the second quarter of 2026, but profitability and operating cash flow weakened sharply. The company also continues to maintain substantial liquidity and has reduced debt from the elevated levels seen in 2023.

  • Liquidity remains solid. Cash and equivalents increased to $948 million in Q2 2026 from $861 million in Q2 2025 and $216 million in Q1 2023. Total current assets of $3.52 billion compared with current liabilities of $1.26 billion, implying a current ratio of approximately 2.8.
  • Debt levels have improved over the longer term. Total short- and long-term debt was approximately $2.28 billion in Q2 2026, down from roughly $2.93 billion in Q2 2023. The quarter included $108 million of debt repayment, offset by an equal amount of new debt issuance.
  • Revenue showed a modest sequential recovery. Q2 2026 revenue rose to $1.85 billion from $1.79 billion in Q1 2026 and $1.76 billion in Q4 2025. However, revenue remained below the $2.07 billion reported in Q2 2023.
  • Divestiture proceeds supported investing cash flow. Ingredion received $127 million from divestitures in Q2 2026, nearly offsetting $100 million of capital spending and resulting in net investing cash outflow of only $2 million.
  • Shareholder distributions remain consistent. The company paid $53 million in dividends during Q2 2026, compared with $54 million in Q2 2025. The reported dividend per share was $0.82 in Q1 2026, up from $0.78 in Q2 2024 and $0.71 in Q2 2023.
  • Equity has strengthened. Total common equity increased to $4.52 billion in Q2 2026 from $4.20 billion in Q2 2025 and $3.38 billion in Q2 2023, helped by growth in retained earnings and a less negative accumulated other comprehensive income balance.
  • Profitability has deteriorated substantially. Q2 2026 gross profit was $426 million, or approximately 23.0% of revenue, down from $477 million, or 26.0% of revenue, in Q2 2025. Operating income fell to $188 million from $271 million, while net income attributable to common shareholders declined to $114 million from $196 million.
  • Earnings per share dropped sharply. Diluted EPS declined to $1.78 in Q2 2026 from $2.99 in Q2 2025 and $2.61 in Q3 2025. The decline occurred despite a slight reduction in diluted shares outstanding, indicating that lower earnings—not dilution—were the primary pressure.
  • Restructuring and interest costs weighed on results. Q2 2026 included a $45 million restructuring charge, compared with $3 million in Q2 2025. Interest expense also jumped to $55 million from $12 million in the prior-year quarter, materially reducing pretax income.
  • Operating cash flow weakened and capital spending exceeded internally generated cash. Cash flow from operations fell to $90 million in Q2 2026 from $185 million in Q2 2025 and $405 million in Q4 2025. After $100 million of capital expenditures, operating cash flow did not cover investment needs without the benefit of divestiture proceeds.

For investors, the key issue is whether Q2’s profit decline reflects temporary restructuring and financing costs or a more persistent margin problem. Ingredion’s strong cash balance, improving equity base and lower long-term debt provide financial flexibility, but the recent decline in gross margin, earnings and operating cash flow warrants close monitoring in upcoming quarters.

11/16/26 03:13 PM ETAI Generated. May Contain Errors.

Ingredion Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ingredion's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Ingredion's net income appears to be on an upward trend, with a most recent value of $736 million in 2025, rising from $412 million in 2015. The previous period was $654 million in 2024. View Ingredion's forecast to see where analysts expect Ingredion to go next.

Ingredion's total operating income in 2025 was $1.02 billion, based on the following breakdown:
  • Total Gross Profit: $1.83 billion
  • Total Operating Expenses: $812 million

Over the last 10 years, Ingredion's total revenue changed from $5.62 billion in 2015 to $7.22 billion in 2025, a change of 28.4%.

In the past 13 quarters, Ingredion's cash and equivalents has ranged from $257 million in Q2 2023 to $989 million in Q3 2026, and is currently $989 million as of their latest financial filing in Q3 2026.

Ingredion had total debt of $2.26 billion at the end of 2025, a 2.3% decrease from 2024, and a 12.7% increase since 2015.

Over the last 10 years, Ingredion's book value per share changed from 29.97 in 2015 to 67.28 in 2025, a change of 124.5%.



Financial statements for NYSE:INGR last updated on 11/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners